| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000772417 |
| P356 | DOI | 10.1007/S00281-016-0578-9 |
| P698 | PubMed publication ID | 27392971 |
| P50 | author | Marcus Altfeld | Q72531060 |
| P2093 | author name string | Madeleine J Bunders | |
| P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 | ||
| Human memory T cells: generation, compartmentalization and homeostasis | Q26851748 | ||
| HIV and aging: emerging research issues | Q27016011 | ||
| Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections | Q27488278 | ||
| A role for mitochondria in NLRP3 inflammasome activation | Q28131794 | ||
| Immunopathogenesis and immunotherapy in AIDS virus infections | Q28183667 | ||
| Mother's little helpers: mechanisms of maternal-fetal tolerance | Q28297770 | ||
| Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group | Q28327789 | ||
| Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal | Q28469094 | ||
| Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial | Q28483723 | ||
| Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries | Q28650579 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 | ||
| Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection | Q30420413 | ||
| Maternal microchimerism in muscle biopsies from children with juvenile dermatomyositis | Q30514100 | ||
| Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa | Q33471468 | ||
| Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
| The effects of maternal helminth and malaria infections on mother-to-child HIV transmission | Q43989249 | ||
| Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? | Q44055963 | ||
| Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women | Q44234789 | ||
| Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. | Q44451245 | ||
| Cellular immune response of fetuses to cytomegalovirus | Q44664158 | ||
| Clinical condition and transmission of coinfections with human cytomegalovirus in infants of HIV-1 infected mothers in the era of mother-to-child-transmission prophylaxis | Q44683283 | ||
| Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. | Q44816481 | ||
| Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile | Q44885039 | ||
| Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production | Q45070393 | ||
| Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. | Q45748047 | ||
| Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study | Q46240018 | ||
| Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants | Q46328518 | ||
| Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire | Q46335753 | ||
| Child mortality according to maternal and infant HIV status in Zimbabwe | Q46339318 | ||
| Placental inflammation and perinatal transmission of HIV-1. | Q46452881 | ||
| A pivotal role for galectin-1 in fetomaternal tolerance | Q46891030 | ||
| Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. | Q47297683 | ||
| Malaria enhances expression of CC chemokine receptor 5 on placental macrophages | Q47879515 | ||
| The outcome of congenital cytomegalovirus infection in relation to maternal antibody status | Q50539344 | ||
| Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. | Q50934933 | ||
| Pro-inflammatory effector Th cells transmigrate through anti-inflammatory environments into the murine fetus. | Q50982599 | ||
| Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. | Q50984331 | ||
| Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. | Q50999795 | ||
| Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. | Q51873133 | ||
| Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. | Q51961945 | ||
| Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. | Q53305666 | ||
| Twenty years of therapy for HIV-1 infection. | Q53382316 | ||
| Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission | Q55546936 | ||
| Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women | Q56837463 | ||
| Increased CD154 Expression in Uninfected Infants Born to HIV-Positive Mothers Exposed to Antiretroviral Prophylaxis | Q56837467 | ||
| HIV-infected pregnant women and vertical transmission in Europe since 1986 | Q56837580 | ||
| Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers | Q57076248 | ||
| Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers | Q57997477 | ||
| T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV | Q57997592 | ||
| CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells | Q58064340 | ||
| HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study | Q58276437 | ||
| Immune cell profile in infants’ lung tissue | Q59737807 | ||
| Increased Natural Killer Cell Activity in Viremic HIV-1 Infection | Q61768285 | ||
| Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. | Q64938887 | ||
| Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF | Q73180266 | ||
| Chimerism of Murine Fetal Bone Marrow by Maternal Cells Occurs in Late Gestation and Persists into Adulthood | Q73392559 | ||
| Immunological response to cytomegalovirus in congenitally infected neonates | Q79780538 | ||
| Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine | Q80072908 | ||
| Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells | Q80507797 | ||
| Altered immunological reactivity in HIV-1-exposed uninfected neonates | Q80924183 | ||
| Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers | Q81516606 | ||
| Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy | Q83709481 | ||
| Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency | Q84229726 | ||
| Racial disparity in the association between body mass index and self-reported asthma in children: a population-based study. | Q40086156 | ||
| A TH1-->TH2 switch is a critical step in the etiology of HIV infection | Q40709038 | ||
| Maternal human immunodeficiency virus status and morbidity and mortality in very low birthweight infants | Q40714946 | ||
| Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors | Q40716631 | ||
| T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission | Q40825900 | ||
| Maternal human immunodeficiency virus status and morbidity and mortality in very low birthweight infants | Q40983236 | ||
| Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis | Q41391515 | ||
| Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding | Q41584640 | ||
| CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus | Q42213414 | ||
| Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa | Q42227184 | ||
| Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy | Q42230946 | ||
| Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers | Q43793133 | ||
| Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency | Q33624111 | ||
| Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. | Q33660894 | ||
| Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals | Q33892180 | ||
| Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression | Q33932713 | ||
| Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant | Q34102747 | ||
| Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs) | Q34200645 | ||
| Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. | Q34245469 | ||
| Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana | Q34306176 | ||
| Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 | ||
| Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1. | Q34397109 | ||
| Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. | Q34406521 | ||
| Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women | Q34530051 | ||
| HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction | Q34687799 | ||
| Clinical malaria diagnosis in pregnancy in relation to early perinatal mother-to-child transmission of HIV: a prospective cohort study | Q34986881 | ||
| Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy | Q34989111 | ||
| The role of the maternal immune system in the regulation of human birthweight | Q35008470 | ||
| In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants | Q35097422 | ||
| Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission | Q35127311 | ||
| Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy | Q35129403 | ||
| Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda | Q35131348 | ||
| Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study | Q35156725 | ||
| HIV-1 pathogenesis | Q35166833 | ||
| The placenta harbors a unique microbiome | Q35171983 | ||
| Natural mechanisms for evading graft rejection: the fetus as an allograft | Q35211602 | ||
| Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. | Q35229722 | ||
| Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism | Q35282764 | ||
| Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. | Q35616368 | ||
| Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy | Q35659264 | ||
| Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia | Q35672554 | ||
| Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents | Q35740081 | ||
| Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. | Q35748412 | ||
| Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy | Q35791312 | ||
| Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. | Q35829767 | ||
| Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies | Q35911374 | ||
| Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants | Q35927408 | ||
| Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa | Q35976283 | ||
| Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection | Q35999709 | ||
| Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission | Q36063383 | ||
| Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
| Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants | Q36315692 | ||
| In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana | Q36389125 | ||
| Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
| Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission | Q36421344 | ||
| Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines | Q36471832 | ||
| Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis. | Q36562812 | ||
| Role of immune activation in progression to AIDS. | Q36571165 | ||
| Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection | Q36678143 | ||
| Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy | Q36816616 | ||
| International perspectives, progress, and future challenges of paediatric HIV infection | Q36872926 | ||
| Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells | Q36882465 | ||
| Does infection with HIV affect the outcome of pregnancy? | Q36894774 | ||
| T cell recognition and immunity in the fetus and mother | Q36963222 | ||
| The trafficking of natural killer cells | Q36990612 | ||
| In utero activation of fetal memory T cells alters host regulatory gene expression and affects HIV susceptibility | Q37051767 | ||
| Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero | Q37111577 | ||
| Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice | Q37398315 | ||
| Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population | Q37423294 | ||
| Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women | Q37598671 | ||
| Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis | Q37718319 | ||
| Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes | Q37889592 | ||
| The impact of differential antiviral immunity in children and adults | Q38037339 | ||
| Fetomaternal immune cross-talk and its consequences for maternal and offspring's health | Q38104878 | ||
| Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child | Q38112591 | ||
| Infections in HIV-exposed uninfected children with focus on sub-Saharan Africa | Q38237157 | ||
| Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study | Q38428546 | ||
| Innate immunity against HIV-1 infection | Q38491184 | ||
| Maternal HIV infection alters the immune balance in the mother and fetus; implications for pregnancy outcome and infant health | Q38672507 | ||
| P2507 | corrigendum / erratum | Erratum to: Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health. | Q50773233 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pregnancy outcome | Q66057507 |
| P577 | publication date | 2016-07-08 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Impact of maternal HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health |
| Q54509804 | Beyond the "take-home baby": pregnancy as a modulator of organ-specific immunity in mother and offspring. |
| Q57296306 | Developmental origin and sex-specific risk for infections and immune diseases later in life |
| Q63677379 | Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa |
| Q50773233 | Erratum to: Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health. | main subject | P921 |
Search more.